NASDAQ:EYESW Second Sight Medical Products (EYESW) Stock Price, News & Analysis → What’s Really Next for America… (From Porter & Company) (Ad) Free EYESW Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.01▼$0.0550-Day Range$0.00▼$0.2252-Week Range$0.18▼$1.02Volume75,101 shsAverage Volume4,500 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesSocial MediaStock AnalysisHeadlinesSocial Media Get Second Sight Medical Products alerts: Email Address Ad InvestorPlaceMillionaire investor and Republican donor makes surprising election predictionFind out who Louis believes is going to win the election... And why that will launch a second boom in AI stocksClick for his six specific AI stock in the crosshairs About Second Sight Medical Products Stock (NASDAQ:EYESW)Read More Ad InvestorPlaceMillionaire investor and Republican donor makes surprising election predictionFind out who Louis believes is going to win the election... And why that will launch a second boom in AI stocksClick for his six specific AI stock in the crosshairs EYESW Stock News HeadlinesMay 2, 2024 | markets.businessinsider.comEye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' AnalystMay 1, 2024 | msn.comVaping poses unexpected risks to eye health, study findsApril 30, 2024 | techcrunch.comneuroClues wants to put high speed eye tracking tech in the doctor’s officeApril 29, 2024 | msn.com10 Things You Should Be Doing Today to Protect Your Eye HealthApril 26, 2024 | detroitnews.comDr. Roach: Eye drops safe to use with AMD medicationApril 23, 2024 | msn.comCrystal Clear Vision: Expert Advice for Preserving Healthy Eyes as You AgeApril 18, 2024 | msn.com'You want it to look perfect because it’s someone’s eye': Ocularists are small group and it's even tougher to get into the industryApril 17, 2024 | theguardian.com‘Pregnancy is not a disease’: why do so many women die giving birth in one of Africa’s richest countries?April 17, 2024 | msn.comMy Miscarriage Was “Common” — For Black Women That Isn’t Comforting, It’s TerrifyingApril 12, 2024 | msn.comFinally, Planned Parenthood will offer sedation for IUD insertions and removalsApril 4, 2024 | msn.comPilot in fatal hot air balloon crash in Arizona had elevated levels of ketamine in his system, report findsApril 3, 2024 | ca.style.yahoo.comThe Good Doctor Cast Exits, Ranked — Which One Hit You the Hardest?April 2, 2024 | msn.comEyestem to initiate human trials for its therapy to treat eye disorderMarch 30, 2024 | msn.com30+ Social Behaviors That Are Only Acceptable in the U.S.March 29, 2024 | msn.comOregon toddler receives life-changing surgery to correct rare eye syndrome: ‘Sassier, more energetic’February 23, 2024 | au.finance.yahoo.comQ4 2023 Evolent Health Inc Earnings CallFebruary 22, 2024 | uk.finance.yahoo.comQ1 2024 Analog Devices Inc Earnings CallFebruary 6, 2024 | msn.comScary but Common Dog ProblemsFebruary 6, 2024 | finance.yahoo.comIridex Corporation Receives European Patent on MicroPulse TechnologyFebruary 5, 2024 | msn.comScientifically Speaking | Eyes are windows to the soul – and the rest of your organsDecember 8, 2023 | msn.comFDA recalls 27 eye products after 4 customers lose eyesightNovember 22, 2023 | msn.comSight Care Review - Eyes Supplement Scam Or Legit To Use? Ingredients, Reviews, And Studies (Critical Update)November 16, 2023 | msn.comSightcare Reviews - What Does Sight Care Official Website Say About Real Customer Results?November 1, 2023 | msn.comFDA Warning: 27 Eye Drop Products Could Cause Eye InfectionsOctober 13, 2023 | msn.comWorld Sight Day: FG launches three policy documents on eye healthSee More Headlines Receive EYESW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Second Sight Medical Products and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorManufacturing Industry Surgical & Medical Instrument Manufacturing Sub-IndustryN/A Current SymbolNASDAQ:EYESW CUSIPN/A CIK1266806 WebN/A PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key Competitors4D pharmaNASDAQ:LBPSWFidelity Select WirelessNASDAQ:FWRLXG Medical InnovationsNASDAQ:GMVDWJupiter WellnessNASDAQ:JUPWWGlobal X Education ETFNASDAQ:EDUTView All Competitors This page (NASDAQ:EYESW) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportGuard Against the Coming Financial UpheavalPorter & CompanyDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Second Sight Medical Products Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
